Mar 19 cystic fibrosis

Notizia

A New Approach to treat Cystic Fibrosis

Researchers at the University of Illinois in Champaign have found that anti-fungal drug amphotericin that helps lung cells to fight chronic bacterial lung infection can help in treating Cystic Fibrosis– a genetic disorder that causes serious damages to lungs. The finding will benefit over 30,000 people in the U.S. and over 70,000 worldwide as presently there exist no effective cure for Cystic Fibrosis.

Scientists are eying an alternative for Statins  

Researchers at Imperial College London’s School of Public Health led a study to find out the effectiveness of bempedoic acid an orally administered medication which inhibits the ability of the body to create cholesterol blocks. This will help patients taking Statins who are unable to cope up with the side effects associated such as muscle pain.

Oral medications aren’t that safe as they appear to be

The study published in the journal Science Translational Medicine revealed that in 90% of the oral medications prescribed in the U.S. contain ingredients that can cause allergies in an inactive form. Chemical food dye in 33%, Lactose in 45%, and Progesterone in almost all the medicines were found in the dormant state.  The study will compel manufacturers to indicate the contents and any such ingredients with the quantity they are present. This will help clinicians while prescribing drugs.

A device to treat Carbon monoxide poisoning gets approval

FDA approved ClearMate– a device consisting of a gas mixer, valves, meters, breathing circuits, an oxygen reservoir, a mask, and hoses, which will help to treat patients suffering from Carbon monoxide poisoning. It will help patients to breathe faster thus helping them to get rid of CO poisoning. This will prove beneficial to many as nearly 500 people die in the U.S. every year.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.